Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in AKBA — Akebia Therapeutics, Inc.

CIK 80255 BALTIMORE, MD
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$351,251
+$4,926 QoQ
Shares Held
308,115
+23.7% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 170 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $2,378,351,093 across 40 Drug Manufacturers - Specialty & Generic names. AKBA ranks #34 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
 68,214,436 $1,083,245,243
2 ALKS
Alkermes plc.
 6,737,328 $353,035,986
3 LNTH
Lantheus Holdings, Inc.
 1,903,354 $211,158,092
4 LQDA
Liquidia Corp
 1,940,364 $154,705,221
5 UTHR
UNITED THERAPEUTICS Corp
 243,444 $131,905,262
6 PRGO
PERRIGO Co plc
 8,700,421 $90,397,373
7 ZTS
Zoetis Inc.
 1,139,097 $81,855,510
8 TEVA
Teva Pharmaceutical Industries Ltd
 1,679,152 $56,889,668

All Filings in AKBA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $351,251 308,115
2026-03-31 $346,325 249,155
2025-12-31 $342,414 212,680
2025-09-30 $554,651 203,169
2025-06-30 $667,080 183,264
2025-03-31 $294,470 153,370
2024-12-31 $262,019 137,905
2024-09-30 $167,175 126,648
2024-06-30 $129,180 126,648
2024-03-31 $109,617 59,900
2023-12-31 $74,276 59,900
2023-09-30 $68,286 59,900
2023-06-30 $75,762 82,800
2023-03-31 $59,080 105,500
2022-12-31 $96,301 166,900
2022-09-30 $52,740 166,900
2022-06-30 $16,626 47,100
2022-03-31 $44,951 62,607
2021-12-31 $100,475 44,458
2021-09-30 $136,967 47,558
2021-06-30 $174,427 46,023
2021-03-31 $144,451 42,674
2020-12-31 $119,680 42,743
2020-09-30 $91,858 36,597
2020-06-30 $374,767 27,597
2020-03-31 $200,051 26,392